Department of Physiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, the Netherlands.
Department of Cardiology, CARIM, Maastricht University Medical Center, Maastricht, the Netherlands.
Europace. 2019 Apr 1;21(4):626-635. doi: 10.1093/europace/euy292.
An appropriate left ventricular (LV) lead position is a pre-requisite for response to cardiac resynchronization therapy (CRT) and is highly patient-specific. The purpose of this study was to develop a non-invasive pre-procedural CRT-roadmap to guide LV lead placement to a coronary vein in late-activated myocardium remote from scar.
Sixteen CRT candidates were prospectively included. Electrocardiographic imaging (ECGI), computed tomography angiography (CTA), and delayed enhancement cardiac magnetic resonance imaging (DE-CMR) were integrated into a 3D cardiac model (CRT-roadmap) using anatomic landmarks from CTA and DE-CMR. Electrocardiographic imaging was performed using 184 electrodes and a CT-based heart-torso geometry. Coronary venous anatomy was visualized using a designated CTA protocol. Focal scar was assessed from DE-CMR. Cardiac resynchronization therapy-roadmaps were constructed for all 16 patients [left bundle branch block: n = 6; intraventricular conduction disturbance: n = 8; narrow-QRS (ablate and pace strategy); n = 1; right bundle branch block: n = 1]. The number of coronary veins ranged between 3 and 4 per patient. The CRT-roadmaps showed no (n = 5), 1 (n = 6), or 2 (n = 5) veins per patient located outside scar in late-activated myocardium [≥50% QRS duration (QRSd)]. Final LV lead position was outside scar in late-activated myocardium in 11 out of 14 implanted patients, while a LV lead in scar was unavoidable in the remaining three patients.
A non-invasive pre-implantation CRT-roadmap was feasible to develop in a case series by integration of coronary venous anatomy, myocardial-scar localization, and epicardial electrical activation patterns, anticipating on clinically relevant features.
合适的左心室(LV)导联位置是心脏再同步治疗(CRT)反应的前提条件,且具有高度的个体特异性。本研究旨在开发一种非侵入性的 CRT 术前路径图,以指导 LV 导联置于远离瘢痕的迟发激活心肌中的冠状静脉内。
前瞻性纳入 16 名 CRT 候选者。心电图成像(ECGI)、计算机断层血管造影(CTA)和延迟增强心脏磁共振成像(DE-CMR)通过 CTA 和 DE-CMR 的解剖学标志整合到 3D 心脏模型(CRT 路径图)中。ECGI 使用 184 个电极和基于 CT 的心脏-胸部几何形状进行。使用指定的 CTA 方案可视化冠状静脉解剖结构。从 DE-CMR 评估局灶性瘢痕。为所有 16 名患者构建 CRT 路径图[左束支传导阻滞:n=6;室内传导障碍:n=8;窄 QRS(消融和起搏策略):n=1;右束支传导阻滞:n=1]。每位患者的冠状静脉数量在 3 至 4 条之间。CRT 路径图显示,在迟发激活心肌中有 0(n=5)、1(n=6)或 2(n=5)条静脉,每条静脉均位于瘢痕之外[≥50% QRS 持续时间(QRSd)]。在 14 名植入患者中,有 11 名最终的 LV 导联位置位于瘢痕之外的迟发激活心肌中,而在其余 3 名患者中,LV 导联位于瘢痕内是不可避免的。
通过整合冠状静脉解剖结构、心肌瘢痕定位和心外膜电激活模式,在病例系列中开发一种非侵入性的 CRT 术前路径图是可行的,该路径图可以预测临床上相关的特征。